Miquel Vila Bover I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR) Instituciones de las que forman parte Jefe de grupo Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca Email Miquel Vila Bover Email Instituciones de las que forman parte Jefe de grupo Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)
I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder. In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN). I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.
Proyectos Mecanismes mol·leculars de mort neuronal en malalties neurodegeneratives i envelliment cerebral IP: - Colaboradores: Miquel Vila Bover, Miriam Izquierdo Sans Entidad financiadora: ICREA Financiación: 58286.68 Referencia: ICREA2005-02 Duración: 04/11/2010 - 04/11/2011 Neuroprotective strategies and biomarkers in Parkinson's disease based on lysosomal impairment IP: Miquel Vila Bover Colaboradores: Jordi Bove Badell, Laia Perez Lasarte Entidad financiadora: Instituto de Salud Carlos III Financiación: 202500 Referencia: MS11/00229 Duración: 01/01/2012 - 31/12/2016 Altered autophagy in Huntington's disease IP: Miquel Vila Bover Colaboradores: Marta Martínez Vicente, Laia Perez Lasarte Entidad financiadora: Instituto de Salud Carlos III Financiación: 243000 Referencia: MS09/00184 Duración: 01/01/2010 - 31/12/2015 Inici, progressió i extensió de la Malaltia de Parkinson: rol de la neuromelanina, alfa-sinucleina i cossos de Lewy IP: Miquel Vila Bover Colaboradores: Laia Perez Lasarte Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: 30000 Referencia: 2011FI_B 00575 Duración: 01/02/2011 - 31/01/2014 Paginación Primera página « Página anterior ‹ … Página 6 Página 7 Página actual 8 Página 9 Página 10 … Siguiente página › Última página »
